Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elion

Showing results (431-440 of 518) with videos related to

Pageof 52
Sort By:
Molecular Cancer Research : MCR|January 1, 2017
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M Williams, Linus Lee, Donna J Hicks, et al.
British Journal of Haematology|January 6, 2016
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective studyJulie Sommet, Corinne Alberti, Nathalie Couque, et al.
Clinical Hemorheology and Microcirculation|March 31, 2012
Relationship between acute chest syndrome and the sympatho-vagal balance in adults with hemoglobin SS disease; a case control studyJennifer M Knight-Madden, Philippe Connes, Andre Bowers, et al.
AIDS (London, England)|August 24, 2017
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomenMonica Gandhi, Pamela M Murnane, Peter Bacchetti, et al.
AIDS (London, England)|March 25, 2020
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxisEric C Tang, Eric Vittinghoff, Susan S Philip, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Acyclovir kinetics after intravenous infusionP de Miranda, R J Whitley, M R Blum, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell DiseaseM de Montalembert, M Belloy, F Bernaudin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 StudyWafaa M El-Sadr, Geetha Beauchamp, H Irene Hall, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2022
Netrin G1 Is a Novel Target Antigen in Primary Membranous NephropathyLinda Reinhard, Maya Machalitza, Thorsten Wiech, et al.
Plos One|February 14, 2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCVSonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, et al.
Pageof 52

Showing results (431-440 of 518) with videos related to

Sort By:
Pageof 52
Molecular Cancer Research : MCR|January 1, 2017
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL BlockadeMichelle M Williams, Linus Lee, Donna J Hicks, et al.
British Journal of Haematology|January 6, 2016
Clinical and haematological risk factors for cerebral macrovasculopathy in a sickle cell disease newborn cohort: a prospective studyJulie Sommet, Corinne Alberti, Nathalie Couque, et al.
Clinical Hemorheology and Microcirculation|March 31, 2012
Relationship between acute chest syndrome and the sympatho-vagal balance in adults with hemoglobin SS disease; a case control studyJennifer M Knight-Madden, Philippe Connes, Andre Bowers, et al.
AIDS (London, England)|August 24, 2017
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomenMonica Gandhi, Pamela M Murnane, Peter Bacchetti, et al.
AIDS (London, England)|March 25, 2020
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxisEric C Tang, Eric Vittinghoff, Susan S Philip, et al.
Clinical Pharmacology and Therapeutics|December 1, 1979
Acyclovir kinetics after intravenous infusionP de Miranda, R J Whitley, M R Blum, et al.
Journal of Pediatric Hematology/Oncology|July 1, 1997
Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell DiseaseM de Montalembert, M Belloy, F Bernaudin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 StudyWafaa M El-Sadr, Geetha Beauchamp, H Irene Hall, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2022
Netrin G1 Is a Novel Target Antigen in Primary Membranous NephropathyLinda Reinhard, Maya Machalitza, Thorsten Wiech, et al.
Plos One|February 14, 2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCVSonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, et al.
Pageof 52